we had kown oppoment of apple so
they did what mistake when opponents of apple
HP, Samsung,
Motorola, HTC and a host of companies are cherished dream tablets were lost when
the focus on hardware that Apple in the race called period of "post-PC" attractive.
Galaxy Tab Samsung,
Motorola Xoom, HP TouchPad
... birth and in turn received much praise for this
is that the value range,
the iPad who was barking. However, as
soon as the iPad second
birth, the
views of analysts has
changed. "When
the competition was trying to imitate the first generation iPad iPad we announced
second and widen the gap in competition, making them once again be left behind," said Steve Jobs
proud.
Apple's CEO bluntly
attacked Xoom priced too high, Galaxy Tab
only small revenues but many others just copy those trips. Synthesis of
Telegraph site that observers seem to agree with the comments of Jobs.
Specialist Adam Leach, the
company Ovum, said: "Apple has the advantage of the lead, but rivals like Samsung, Motorola, HP, HTC and RIM
are also just trying to repeat that experience that gives Apple users, instead of bringing something new. "
Sarah Rotman Epps, a
researcher at Forrester Research, commented: "The product
competes with iPad may sound impressive, but wrong about
the distribution strategy with the price too high because the price of 500 USD iPad very difficult to overcome.
Carolina
Milanesi of Gartner also said that the tablet manufacturers are still not overcome the disadvantages
that the phone
companies suffer when
competing with the iPhone: they try
to create a hardware
war. They
are proud of offering
the full range of connectivity, powerful processor, capable of multitasking operation "real" ...
But eventually, high profile enough not to those
"little pet" their sales
of 100 million
just as the iPhone version with 4 or
15 million after just one year as the iPad. One can
see Xoom than this,
than the other TouchPad with Apple's
tablet, but a comprehensive review, it does not
feel disruptive.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment